ARVN · Arvinas, Inc. · Executive Compensation

$7.64 -0.10 (-1.29%)

Russell 2000 member Rebalance outlook locked

Market Cap

$486.47M

65.39M

Volume · Oct 1 263.33K Avg daily vol (3M) 784.12K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$706,236	—	$2,685,840	$2,671,051	$457,000	$14,000	$6,534,127
John Houston	Former President and Chief Executive Officer	$706,236	—	$2,685,840	$2,671,051	$457,000	$14,000	$6,534,127
Noah Berkowitz	M.D., Ph.D. Chief Medical Officer	$552,387	—	$1,369,852	$1,389,217	$268,500	$14,000	$3,593,956
Andrew Saik	Chief Financial Officer and Treasurer	$542,063	—	$1,261,412	$1,281,339	$263,500	$14,000	$3,362,314
Angela Cacace	Chief Scientific Officer	$500,763	—	$1,261,412	$1,281,339	$243,400	$14,000	$3,300,914
Ian Taylor	Former President of Research and Development	$152,567	—	$364,338	$362,468	—	$24,016	$903,389

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$684,005	—	$5,849,150	$5,773,207	$426,819	$13,800	$12,746,981
John Houston	President and Chief Executive Officer	$684,005	—	$5,849,150	$5,773,207	$426,819	$13,800	$12,746,981
Noah Berkowitz	M.D., Ph.D. Chief Medical Officer	$421,827	—	$2,703,055	$2,645,753	$197,500	$13,800	$5,981,935
Ian Taylor	President of Research and Development	$367,937	—	$1,844,750	$1,820,973	$172,200	$13,800	$4,219,660
Randy Teel	Former interim Chief Financial Officer	$474,998	—	$1,546,216	$1,519,019	$222,300	$13,800	$3,776,333
Andrew Saik	Chief Financial Officer and Treasurer	$272,596	—	$1,533,383	$1,527,571	$127,600	$4,846	$3,465,996
Angela Cacace	Chief Scientific Officer	$464,753	—	$1,143,160	$1,132,996	$217,600	$13,800	$2,972,309
Sean Cassidy	Former Chief Financial Officer and Treasurer	$92,265	—	—	—	—	$13,643	$105,908

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Houston	President and Chief Executive Officer	$657,697	—	$2,130,081	$4,352,454	$473,600	$13,200	$7,627,032
John G. Houston	CEO	$657,697	—	$2,130,081	$4,352,454	$473,600	$13,200	$7,627,032
Ronald Peck	—	$473,443	—	$657,326	$1,343,303	$255,700	$13,200	$2,742,972
Ian Taylor	President of Research and Development	$466,856	—	$657,326	$1,343,303	$252,200	$13,200	$2,732,885
Sean Cassidy	Former Chief Financial Officer and Treasurer	$460,617	—	$657,326	$1,343,303	$248,800	$13,200	$2,723,246

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Houston	President and Chief Executive Officer	$632,401	—	—	$8,467,445	$433,800	$12,200	$9,545,846
John G. Houston	CEO	$632,401	—	—	$8,467,445	$433,800	$12,200	$9,545,846
Former Chief Medical	Officer	$455,233	—	—	$2,829,043	$234,200	$12,200	$3,530,676
Ronald Peck	Chief Medical Officer	$455,233	—	—	$2,829,043	$234,200	$12,200	$3,530,676
Ian Taylor	President of Research and Development	$448,900	—	—	$2,829,043	$230,900	$12,200	$3,521,043
Sean Cassidy	Former Chief Financial Officer and Treasurer	$442,901	—	—	$2,829,043	$227,900	$12,200	$3,512,044

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$584,051	—	—	$11,532,263	$473,100	$11,600	$12,601,014
John Houston	President and Chief Executive Officer	$584,051	—	—	$11,532,263	$473,100	$11,600	$12,601,014
Former Chief Medical	Officer	$435,630	—	—	$3,572,466	$264,700	$11,600	$4,284,396
Ronald Peck	Chief Medical Officer	$435,630	—	—	$3,572,466	$264,700	$11,600	$4,284,396
Ian Taylor	Chief Scientific Officer	$420,000	—	—	$3,572,466	$255,200	$11,600	$4,259,266
Sean Cassidy	Former Chief Financial Officer	$408,126	—	—	$3,572,466	$248,000	$11,600	$4,240,192

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$564,300	—	—	$6,989,781	$454,300	$11,400	$8,019,781
John Houston	President and Chief Executive Officer	$564,300	—	—	$6,989,781	$454,300	$11,400	$8,019,781
Ronald Peck	Chief Medical Officer	$418,000	—	—	$2,231,063	$269,200	—	$2,918,263
Ronal Peck	M.D., Chief Medical Officer	$418,000	—	—	$2,231,063	$269,200	—	$2,918,263
Ian Taylor	Chief Scientific Officer	$400,000	—	—	$2,231,063	$257,700	$11,400	$2,900,163
Sean Cassidy	Chief Financial Officer	$375,000	—	—	$2,231,063	$242,000	$11,400	$2,859,463

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$527,500	—	$1,356,013	$3,180,326	$422,000	$11,200	$5,497,039
John Houston	President and Chief Executive Officer	$527,500	—	$1,356,013	$3,180,326	$422,000	$11,200	$5,497,039
Sean Cassidy	Chief Financial Officer	$336,500	—	$371,034	$1,095,988	$215,400	$11,200	$2,030,122
Ronal Peck	M.D., Chief Medical Officer	$174,282	$3,000	$426,370	$1,213,594	$100,300	—	$1,917,546
Ronald Peck	Chief Medical Officer	$174,282	$3,000	$426,370	$1,213,594	$100,300	—	$1,917,546
Ian Taylor	Chief Scientific Officer	$315,000	—	$207,965	$817,152	$193,800	$11,200	$1,545,117

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John G. Houston	CEO	$427,770	—	$942,373	$4,631,313	$278,100	—	$6,279,556
John Houston	President and Chief Executive Officer	$427,770	—	$942,373	$4,631,313	$278,100	—	$6,279,556
Sean Cassidy	Chief Financial Officer	$265,753	—	$799,498	$1,597,453	$138,200	—	$2,800,904
Ian Taylor	Ph.D., Chief Scientific Officer	$286,713	—	$562,647	$998,224	$137,800	—	$1,985,384
Ronal Peck	M.D., Chief Medical Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Randy Teel, Ph.D.	president, CEO, and principal executive officer	Appointed	2026-02-12	2026-02-12
Randy Teel, Ph.D.	member of the Board	Appointed	2026-02-12	2026-02-12
Briggs Morrison, M.D.	chair of the Board	Appointed	2026-02-12	2026-02-12
John Houston, Ph.D.	chairperson of the Company's board of directors	Resigned	2026-02-12	2026-02-12
John Houston, Ph.D.	president, chief executive officer ("CEO") and chairperson of the Company's board of directors	Resigned	2026-02-12	2026-02-12
Laurie Smaldone Alsup	Class I directors	Appointed	—	2025-06-30
John Houston	Class I directors	Appointed	—	2025-06-30
Linda Bain	Class I directors	Appointed	—	2025-06-30
John Young	Board of Directors	Resigned	2025-06-30	2025-06-30
Ian Taylor, Ph.D.	President of Research and Development	Resigned	2025-06-06	2025-06-06
Andrew Saik	chief financial officer, treasurer and principal financial officer	Appointed	2024-06-24	2024-06-24
Noah Berkowitz, M.D., Ph.D.	chief medical officer	Appointed	2024-03-18	2024-03-18
Randy Teel	interim Chief Financial Officer, Treasurer and principal financial officer	Appointed	2024-02-29	2024-02-20
Sean Cassidy	Chief Financial Officer, Treasurer and principal financial officer	Resigned	2024-02-29	2024-02-20
Everett Cunningham	director	Appointed	2022-12-15	2022-12-16
David Loomis	principal accounting officer	Appointed	2022-12-15	2022-12-16
Bradley Margus	Board of Directors	Resigned	2022-12-15	2022-12-16
John Young	Class II director	Appointed	2022-08-18	2022-08-19
Liam Ratcliffe	Board of Directors	Resigned	2022-08-16	2022-08-19

Key facts CIK 1655759 CUSIP 04335A105 13F (30d) 6 filings 6 filers Visit website Investor relations